T-SPOT.CMV and T-SPOT.PRT Diagnostic Assays

CompletedOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Infection in Solid Organ Transplant Recipients
Trial Locations (39)

10029

ICON School of Medicine at Mt Sinai, New York

10467

Montefiore Medical Center, The Bronx

13210

SUNY, Syracuse

14215

Erie County Medical Center, Buffalo

20007

Georgetown University, Washington D.C.

29425

Medical University of South Carolina, Charleston

30322

Emory University, Atlanta

30912

Georgia Regents University, Augusta

33331

Cleveland Clinic, Weston

33606

Tampa General Hospital, Tampa

44106

Case Medical Center, Cleveland

45219

University of Cincinnati, Cincinnati

63110

Washington University, St Louis

70130

Ochsner Clinic Foundation, New Orleans

75246

Baylor University Medical Center, Dallas

76104

Baylor All Saints Medical Center, Fort Worth

77030

Houston Methodist, Houston

80045

University of Colorado, Aurora

84107

Intermoutain Health Care, Salt Lake City

85721

University of Arizona, Tucson

90057

Transplant Research Institute, Los Angeles

92354

Loma Linda University Medical Center, Loma Linda

92710

Legacy Transplant Services, Portland

92868

University of California, Irvine

94143

University of California - San Francisco, San Francisco

94415

California Pacific Medical Center, San Francisco

98122

University of Washington, Seattle

99204

Providence Health and Services, Spokane

Unknown

U Maryland, Baltimore

U Nebraska, Omaha

St Barnabas Medical Center, Livingston

Albany Medical Center, Albany

University of Toledo Medical Center, Toledo

Baylor College of Medicine, Houston

Queen Elizabeth Hospital, Birmingham

Guy's Hospital, London

Churchill Hospital, Oxford

02144

Massachusetts General Hospital, Boston

m5g 2n2

University Health Network, Toronto

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Oxford Immunotec

INDUSTRY